Forchheim, Germany Clinical Trials

A listing of Forchheim, Germany clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 44 clinical trials
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

The purpose of the study is to evaluate efficacy and safety of Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-Edotreotide compared to targeted molecular therapy with Everolimus in patients with inoperable, progressive, somatostatin receptor-positive (SSTR+), neuroendocrine tumours of gastroenteric or pancreatic origin (GEP-NET).

somatostatin
everolimus
progressive disease
edotreotide
radionuclide therapy
Universit tsklinikum Erlangen
 (8.7 away) Contact site
  • 220 views
  • 16 Aug, 2020
  • +65 other locations
Renal Denervation in Chronic Kidney Disease - RDN-CKD Study

RDN-CKD Study is a prospective, randomized (1:1, central randomization), double-blind (unblinded interventionalist and blinded study team at each center), sham controlled, multicenter feasibility study. The purpose of the RDN-CKD Study is to demonstrate that renal denervation (RDN) effectively reduces 24-h ambulatory BP in 80 patients with chronic kidney disease (CKD) …

Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nuremberg
 (8.7 away) Contact site
  • 0 views
  • 16 Feb, 2020
  • +3 other locations
A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD)

The aim of this study is to assess the therapeutic efficacy of secukinumab on the psoriatic skin and to explore the anti-inflammatory (reduction of hepatic inflammation and cell damage), anti-steatotic (reduction of hepatic triglyceride content) and anti-fibrotic (reduction of hepatic fibrosis) effects of secukinumab in patients with psoriasis and coexisting …

hepatic fibrosis
systemic therapy
fibrosis
fatty liver
secukinumab
Novartis Investigative Site
 (8.7 away) Contact site
  • 5 views
  • 08 Oct, 2020
  • +10 other locations
Impact of Remission Induction Chemotherapy Prior to Allogeneic SCT in Relapsed and Poor-response Patients With AML

This trial compares outcome of two treatment strategies for patients with high-risk AML who failed to achieve or maintain a complete remission with standard therapy. Patients will be randomized between two strategies. The standard strategy is aimed at achieving a complete remission by aggressive salvage chemotherapy using high dose cytarabine …

remission
mitoxantrone
neoadjuvant therapy
induction chemotherapy
cytarabine
Universit tsklinikum Erlangen
 (8.7 away) Contact site
  • 45 views
  • 05 Aug, 2020
  • +17 other locations